Rom S. Leidner

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

Thomas Duhen, Rebekka Duhen, Ryan Montler et al. · Nature Communications · 2018 · 946 citations · Full text

Life Sciences, Immunology, Oncology +17

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco et al. · Journal for ImmunoTherapy of Cancer · 2019 · 738 citations · Full text

Medicine, Immunology, Oncology +13

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

Rom S. Leidner, Nelson Sanjuan Silva, Huayu Huang et al. · New England Journal of Medicine · 2022 · 509 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Robert L. Ferris, William C. Spanos, Rom S. Leidner et al. · Journal for ImmunoTherapy of Cancer · 2021 · 222 citations · Full text

Medicine, Oncology, Pharmacology +17

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington et al. · Annals of Oncology · 2018 · 211 citations · Full text

Medicine, Immunology, Oncology +16